NO20022336L - Nye tiazolidin-dion-derivater som antidiabetiske midler - Google Patents

Nye tiazolidin-dion-derivater som antidiabetiske midler

Info

Publication number
NO20022336L
NO20022336L NO20022336A NO20022336A NO20022336L NO 20022336 L NO20022336 L NO 20022336L NO 20022336 A NO20022336 A NO 20022336A NO 20022336 A NO20022336 A NO 20022336A NO 20022336 L NO20022336 L NO 20022336L
Authority
NO
Norway
Prior art keywords
antidiabetic agents
dione derivatives
new thiazolidinedione
thiazolidinedione
new
Prior art date
Application number
NO20022336A
Other languages
English (en)
Other versions
NO20022336D0 (no
Inventor
Marisabel Mourelle Mancini
Elisabet De Ramon Amat
Juan Carlos Del Castillo Nieto
Original Assignee
Vita Invest Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vita Invest Sa filed Critical Vita Invest Sa
Publication of NO20022336D0 publication Critical patent/NO20022336D0/no
Publication of NO20022336L publication Critical patent/NO20022336L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
NO20022336A 1999-11-18 2002-05-15 Nye tiazolidin-dion-derivater som antidiabetiske midler NO20022336L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009902533A ES2156574B1 (es) 1999-11-18 1999-11-18 Nuevos derivados de tiazolidindiona como agentes antidiabeticos
PCT/ES2000/000432 WO2001036416A1 (es) 1999-11-18 2000-11-15 Nuevos derivados de tiazolidindiona como agentes antidiabeticos

Publications (2)

Publication Number Publication Date
NO20022336D0 NO20022336D0 (no) 2002-05-15
NO20022336L true NO20022336L (no) 2002-07-09

Family

ID=8310628

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20022336A NO20022336L (no) 1999-11-18 2002-05-15 Nye tiazolidin-dion-derivater som antidiabetiske midler
NO20022379A NO20022379D0 (no) 1999-11-18 2002-05-16 Nye tiazolidinedionderivater som antidiabetiske midler

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20022379A NO20022379D0 (no) 1999-11-18 2002-05-16 Nye tiazolidinedionderivater som antidiabetiske midler

Country Status (37)

Country Link
US (1) US7001910B1 (no)
EP (1) EP1231211B1 (no)
JP (1) JP2003514817A (no)
KR (1) KR100518110B1 (no)
CN (1) CN1159314C (no)
AP (1) AP1330A (no)
AR (1) AR031080A1 (no)
AT (1) ATE241622T1 (no)
AU (1) AU770045B2 (no)
BG (1) BG106699A (no)
BR (1) BR0015613A (no)
CA (1) CA2391913A1 (no)
CO (1) CO5261560A1 (no)
CR (1) CR6640A (no)
CZ (1) CZ20021654A3 (no)
DE (1) DE60003072T2 (no)
DK (1) DK1231211T3 (no)
EA (1) EA004301B1 (no)
EE (1) EE200200254A (no)
ES (2) ES2156574B1 (no)
GE (1) GEP20043240B (no)
HR (1) HRP20020426A2 (no)
HU (1) HUP0203478A2 (no)
IL (1) IL149634A0 (no)
IS (1) IS2014B (no)
MA (1) MA26844A1 (no)
MX (1) MXPA02005011A (no)
NO (2) NO20022336L (no)
NZ (1) NZ519264A (no)
OA (1) OA12089A (no)
PE (1) PE20010858A1 (no)
PL (1) PL354877A1 (no)
PT (1) PT1231211E (no)
SK (1) SK6752002A3 (no)
WO (1) WO2001036416A1 (no)
YU (1) YU40202A (no)
ZA (1) ZA200203906B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2174748B1 (es) * 2001-01-31 2003-09-16 Vita Lab Nueva sal de tiazolidindiona y sus polimorfos como agentes antidiabeticos y procedimiento para la obtencion de los mismos.
KR100450700B1 (ko) * 2002-03-22 2004-10-01 주식회사종근당 티아졸리딘디온 유도체 화합물 및 이를 함유하는 약제학적조성물
US7713983B2 (en) 2003-03-03 2010-05-11 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
CL2004000409A1 (es) 2003-03-03 2005-01-07 Vertex Pharma Compuestos derivados de 2-(cilo sustituido)-1-(amino u oxi sustituido)-quinazolina, inhibidores de canales ionicos de sodio y calcio dependientes de voltaje; composicion farmaceutica; y uso del compuesto en el tratamiento de dolor agudo, cronico, neu
US20050014732A1 (en) * 2003-03-14 2005-01-20 Pharmacia Corporation Combination of an aldosterone receptor antagonist and an anti-diabetic agent
US7928107B2 (en) 2004-09-02 2011-04-19 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
US8283354B2 (en) 2004-09-02 2012-10-09 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
CZ297347B6 (cs) * 2004-09-21 2006-11-15 Zentiva, A. S. Zpusob prípravy rosiglitazonu
JP5546372B2 (ja) * 2010-06-30 2014-07-09 積水メディカル株式会社 ベンジルヒダントイン化合物の製造法
WO2016184895A1 (en) 2015-05-18 2016-11-24 Institut National De La Sante Et De La Recherche Medicale (Inserm) Means for detecting or measuring a biological activity of a botulinum toxin
US10689374B1 (en) 2019-07-12 2020-06-23 United Arab Emirates University Pyrimidine-thiazolidinone derivatives
US10702525B1 (en) 2019-09-04 2020-07-07 United Arab Emirates University Pyrimidine derivatives as anti-diabetic agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR240698A1 (es) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
ES2137915T3 (es) * 1987-09-04 2000-01-01 Beecham Group Plc Derivados de tiazolidindiona sustituida.
GB9023583D0 (en) * 1990-10-30 1990-12-12 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
PT1231211E (pt) 2003-09-30
IS2014B (is) 2005-06-15
CN1402724A (zh) 2003-03-12
ATE241622T1 (de) 2003-06-15
CZ20021654A3 (cs) 2002-09-11
BR0015613A (pt) 2002-07-23
EA200200470A1 (ru) 2002-10-31
OA12089A (en) 2006-05-04
MA26844A1 (fr) 2004-12-20
KR100518110B1 (ko) 2005-10-04
MXPA02005011A (es) 2003-10-14
SK6752002A3 (en) 2002-09-10
WO2001036416A1 (es) 2001-05-25
NO20022379D0 (no) 2002-05-16
ES2156574A1 (es) 2001-06-16
ES2156574B1 (es) 2002-02-01
BG106699A (bg) 2003-02-28
YU40202A (sh) 2006-01-16
AR031080A1 (es) 2003-09-10
HRP20020426A2 (en) 2004-02-29
ZA200203906B (en) 2004-03-26
DE60003072T2 (de) 2004-04-01
AU770045B2 (en) 2004-02-12
EP1231211A1 (en) 2002-08-14
KR20020079737A (ko) 2002-10-19
GEP20043240B (en) 2004-05-25
EA004301B1 (ru) 2004-02-26
IS6386A (is) 2002-05-15
AP1330A (en) 2004-11-25
DK1231211T3 (da) 2003-10-27
AU1281501A (en) 2001-05-30
US7001910B1 (en) 2006-02-21
CO5261560A1 (es) 2003-03-31
PL354877A1 (en) 2004-03-08
NZ519264A (en) 2003-10-31
DE60003072D1 (de) 2003-07-03
CR6640A (es) 2004-03-05
JP2003514817A (ja) 2003-04-22
EE200200254A (et) 2003-06-16
CA2391913A1 (en) 2001-05-25
HUP0203478A2 (hu) 2003-02-28
ES2199878T3 (es) 2004-03-01
IL149634A0 (en) 2002-11-10
NO20022336D0 (no) 2002-05-15
CN1159314C (zh) 2004-07-28
AP2002002512A0 (en) 2002-06-30
EP1231211B1 (en) 2003-05-28
PE20010858A1 (es) 2001-08-22

Similar Documents

Publication Publication Date Title
NO20022502D0 (no) Nye antidiabetiske midler
NO20041567L (no) 1,8-nafthyridinderivater som antidiabetiske midler
NO20022556L (no) Nye benzoimidazolderivater nyttige som antiproliferative midler
NO20014412L (no) Forbindelser nyttige som anti-inflammatoriske midler
NO20013671L (no) Substituerte bisycliske derivater nyttige som anticancer midler
NO20042372L (no) Nye 1,2,4-tiadiazolderivater som melanokortinreseptormodulatorer
CY2008018I2 (el) Παραγωγα 6-μepκαπτο-κυκλοδεξτρινης: παραγοντες αναστροφης του νευρoμυϊκου αποκλεισμου που προκαλειται απο φαρμακευτικες ουσιες
DK1157023T3 (da) C-21-modificerede epothiloner
NO20015477D0 (no) 4,5,6,7-tetrahydroindazol-derivater som anti-tumor midler
ATE391505T1 (de) Benzothiazole derivative
NO20021459L (no) Piperazin-derivater som 5-HT1B-antagonister
DK1237857T3 (da) Nye Phenalkyloxyphenylderivater
NO20022336L (no) Nye tiazolidin-dion-derivater som antidiabetiske midler
NO20021251D0 (no) Tienoisoksazolyl- og tienylpyrrazolyl-fenoksysubstituerte propylderivater anvendelige som D4antagonister
DK1464641T3 (da) 4-phenylpiperazinyl-, -piperidinyl- og -tetrahydropyridylderivater som dopamin-D4-antagonister
NO20020457D0 (no) Benzenaminderivater som antikoagulanter
NO20023001D0 (no) Substituerte piperazinderivater som MTP inhibitorer
DK1075471T3 (da) Idolylderivater som serotonerge midler
DK1173436T3 (da) Thiazolidindionderivat og anvendelse deraf som antidiabetikum
DK1015446T3 (da) 4-(Piperidinyl)-1H-2-benzopyranderivater, der er nyttige som antipsykotiske midler
NO20001751D0 (no) Nye forbindelser til bruk som neuroprotektive midler
DK1073651T3 (da) Indolylderivater som serotonerge midler
NO20031434L (no) Tiazolidindionderivater og deres anvendelse som antidiabetiske midler
NO20053117D0 (no) Cyklopenta[c]isoksazol-3-aminer anvendt som materialbeskyttelsesmidler.
NO20021249D0 (no) Tienoisoksazolfenoksyusubstituerte etyl- og propylderivater som D4antagonister

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application